<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35380400</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6903</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurochemical research</Title><ISOAbbreviation>Neurochem Res</ISOAbbreviation></Journal><ArticleTitle>Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.</ArticleTitle><Pagination><StartPage>1816</StartPage><EndPage>1829</EndPage><MedlinePgn>1816-1829</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-022-03591-3</ELocationID><Abstract><AbstractText>The medicinal plant Mucuna pruriens (Fabaceae) is widely known for its anti-oxidative and anti-inflammatory properties. It is a well-established drug in Ayurveda and has been widely used for the treatment of neurological disorders and male infertility for ages. The seeds of the plant have potent medicinal value and its extract has been tested in different models of neurodegenerative diseases, especially Parkinson's disease (PD). Apart from PD, Mucuna pruriens is now being studied in models of other nervous systems disorders such as Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS) and stroke because of its neuroprotective importance. This review briefly discusses the pathogenesis of PD, AD, ALS and stroke. It aims to summarize the medicinal importance of Mucuna pruriens in treatment of these diseases, and put forward the potential targets where Mucuna pruriens can act for therapeutic interventions. In this review, the effect of Mucuna pruriens on ameliorating the neurodegeneration evident in PD, AD, ALS and stroke is briefly discussed. The potential targets for neuroprotection by the plant are delineated, which can be studied further to validate the hypothesis regarding the use of Mucuna pruriens for the treatment of these diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zahra</LastName><ForeName>Walia</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birla</LastName><ForeName>Hareram</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Saumitra Sen</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rathore</LastName><ForeName>Aaina Singh</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilnashin</LastName><ForeName>Hagera</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Richa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keshri</LastName><ForeName>Priyanka Kumari</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gautam</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Surya Pratap</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India. suryasinghbhu16@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurochem Res</MedlineTA><NlmUniqueID>7613461</NlmUniqueID><ISSNLinking>0364-3190</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D031299" MajorTopicYN="Y">Mucuna</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012639" MajorTopicYN="N">Seeds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Medicinal plant</Keyword><Keyword MajorTopicYN="N">Mucuna pruriens</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35380400</ArticleId><ArticleId IdType="doi">10.1007/s11064-022-03591-3</ArticleId><ArticleId IdType="pii">10.1007/s11064-022-03591-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mannangatti P, Naidu KN (2016) Indian herbs for the treatment of neurodegenerative disease. In: Essa Mohamed, Akbar Mohammed, Guillemin Gilles (eds) The Benefits of Natural Products for Neurodegenerative Diseases, M. Springer, Cham, pp 323&#x2013;336</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-28383-8_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra LC (ed) (2003) Scientific basis for Ayurvedic therapies. Routledge, London</Citation></Reference><Reference><Citation>Pathania R, Chawla P, Khan H, Kaushik R, Khan MA (2020) An assessment of potential nutritive and medicinal properties of Mucuna pruriens: a natural food legume. 3 Biotech. 10:1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-020-02253-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S, Prithiviraj E, Lakshmi NV, Ganesh MK, Ganesh L, Prakash S (2013) Effect of Mucuna pruriens (Linn.) on mitochondrial dysfunction and DNA damage in epididymal sperm of streptozotocin induced diabetic rat. Journal of Ethnopharmacology. 145(1):32&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">23103904</ArticleId><ArticleId IdType="doi">10.1016/j.jep.2012.10.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JA (2008) Duke&#x2019;s handbook of medicinal plants of Latin America. CRC Press, London</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/9781420043174</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaweera DM (1982) Medicinal plants used in Ceylon Part 3(442):161</Citation></Reference><Reference><Citation>Sathiyanarayanan L, Arulmozhi S (2007) Mucuna pruriens Linn.- a comprehensive review. Pharmacognosy Rev 1(1):157&#x2013;162</Citation></Reference><Reference><Citation>Bhaskar A, Nithya V, Vidhya VG (2011) Phytochemical evaluation by GC-MS and antihyperglycemic activity of Mucuna pruriens on streptozotocin induced diabetes in rats. J Chem Pharm Res 3(5):689&#x2013;696</Citation></Reference><Reference><Citation>Rakesh B, Praveen N. Chapter-10 biotechnological approaches for the production of l-DOPA: a novel and potent anti-Parkinson&#x2019;s drug from Mucuna pruriens (L.) DC. Chief Editor. 2020;179.</Citation></Reference><Reference><Citation>Amin KY, Khan MN, Zillur-Rehman S, Khan NA (1996) Sexual function improving effect of Mucuna pruriens in sexually normal male rats. Fitoterapia (Milano). 67(1):53&#x2013;8</Citation></Reference><Reference><Citation>Adepoju GK, Odubena OO (2009) Effect of Mucuna pruriens on some haematological and biochemical parameters. J Med Plants Res 3(2):73&#x2013;76</Citation></Reference><Reference><Citation>Yadav SK, Prakash J, Chouhan S, Singh SP (2013) Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model. Neurochem Int 62(8):1039&#x2013;1047</Citation><ArticleIdList><ArticleId IdType="pubmed">23562769</ArticleId><ArticleId IdType="doi">10.1016/j.neuint.2013.03.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanasekaran M, Tharakan B, Manyam BV (2008) Antiparkinson drug&#x2013;Mucuna pruriens shows antioxidant and metal chelating activity. Phytother Res 22(1):6&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pubmed">18064727</ArticleId><ArticleId IdType="doi">10.1002/ptr.2109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushpalatha B, Venumadhav N, Swathi M, Raju BA (2013) Neuroprotective effect of resveratrol against scopolamine-induced cognitive impairment and oxidative stress in rats. Arch Biol Sci 65(4):1381&#x2013;1386</Citation><ArticleIdList><ArticleId IdType="doi">10.2298/ABS1304381P</ArticleId></ArticleIdList></Reference><Reference><Citation>Fothergill-Misbah N, Maroo H, Cham M, Pezzoli G, Walker R, Cilia R (2020) Could Mucuna pruriens be the answer to Parkinson&#x2019;s disease management in sub-Saharan Africa and other low-income countries worldwide? Parkinsonism Relat Disord 1(73):3&#x2013;7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond SG, Marchkham CH, Hoehn MM, McDowell FH, Muenter MD (1987) Multi-center study of Parkinson mortality with early versus later dopa treatment. Ann Neurol 22(1):8&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">3631925</ArticleId><ArticleId IdType="doi">10.1002/ana.410220105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Birla H, Singh SS, Zahra W, Patil RR, Jadhav JP, Gedda MR, Singh SP (2017) Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson&#x2019;s disease through NF-&#x3ba;B/pAKT signaling pathways. Front Aging Neurosci 19(9):421</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Birla H, Zahra W, Singh SS, Singh SP (2017) Immunomodulation of Parkinson&#x2019;s disease using Mucuna pruriens (Mp). J Chem Neuroanat 1(85):27&#x2013;35</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2017.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK (2019) Plant extracts and phytochemicals targeting &#x3b1;-synuclein aggregation in Parkinson&#x2019;s disease models. Front Pharmacol 19(9):1555</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.01555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed MS, Tripathi MK, Mishra AK, Shukla S, Singh MP (2016) Resveratrol protects from toxin-induced parkinsonism: plethora of proofs hitherto petty translational value. Molecular neurobiology. 53(5):2751&#x2013;60</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9124-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelders G, Baekelandt V, Van der Perren A (2018) Linking neuroinflammation and neurodegeneration in Parkinson&#x2019;s disease. J Immunol Res 2018:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4784268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiglieri V, Calabrese V, Calabresi P (2018) Alpha-synuclein: from early synaptic dysfunction to neurodegeneration. Front Neurol 4(9):295</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson&#x2019;s disease. Transl Neurodegen 5(1):1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0049-6</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin&#x2013;proteasome system in Parkinson&#x2019;s disease. Nat Rev Neurosci 2(8):589&#x2013;594</Citation><ArticleIdList><ArticleId IdType="pubmed">11484002</ArticleId><ArticleId IdType="doi">10.1038/35086067</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao RV, Bredesen DE (2004) Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 16(6):653&#x2013;662</Citation><ArticleIdList><ArticleId IdType="pubmed">15530777</ArticleId><ArticleId IdType="pmc">3970707</ArticleId><ArticleId IdType="doi">10.1016/j.ceb.2004.09.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson KE, Gendelman HE (2016) Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson&#x2019;s disease. Curr Opin Pharmacol 1(26):87&#x2013;95</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2015.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 18(8):77</Citation></Reference><Reference><Citation>Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">17180163</ArticleId><ArticleId IdType="doi">10.1038/nrn2038</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T (2006) Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci 1088(1):219&#x2013;229</Citation><ArticleIdList><ArticleId IdType="pubmed">17192568</ArticleId><ArticleId IdType="doi">10.1196/annals.1366.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidi F (2000) Antioxidants in food and food antioxidants. Food Nahrung 44(3):158&#x2013;163</Citation><ArticleIdList><ArticleId IdType="pubmed">10907235</ArticleId><ArticleId IdType="doi">10.1002/1521-3803(20000501)44:3&lt;158::AID-FOOD158&gt;3.0.CO;2-L</ArticleId></ArticleIdList></Reference><Reference><Citation>Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S (2001) Green tea polyphenol (&#x2013;)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78(5):1073&#x2013;1082</Citation><ArticleIdList><ArticleId IdType="pubmed">11553681</ArticleId><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00490.x</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho MC, Barca FN, Agnez-Lima LF, de Medeiros SR (2003) Evaluation of mutagenic activity in an extract of pepper tree stem bark (Schinus terebinthifolius Raddi). Environ Mol Mutagen 42(3):185&#x2013;191</Citation><ArticleIdList><ArticleId IdType="pubmed">14556225</ArticleId><ArticleId IdType="doi">10.1002/em.10183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Machado SC, Rodrigues MP, Nunes AP, Dantas FJ, De Mattos JC, Silva CR, Moura EG, Bezerra RJ, Caldeira-de-Araujo A (2004) Genotoxic potentiality of aqueous extract prepared from Chrysobalanus icaco L. leaves. Toxicol Lett 151(3):481&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">15261992</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2004.03.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyam BV, Dhanasekaran M, Hare TA (2004) Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Phytother Res 18(2):97&#x2013;101</Citation><ArticleIdList><ArticleId IdType="pubmed">15022157</ArticleId><ArticleId IdType="doi">10.1002/ptr.1407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WS, K&#xe5;gedal K, Halliday GM (2014) Alpha-synuclein biology in Lewy body diseases. Alzheimer&#x2019;s Res Ther 6(5):1&#x2013;9</Citation></Reference><Reference><Citation>Luk KC, Kehm V, Carroll J, Zhang B, O&#x2019;Brien P, Trojanowski JQ, Lee VM (2012) Pathological &#x3b1;-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949&#x2013;953</Citation><ArticleIdList><ArticleId IdType="pubmed">23161999</ArticleId><ArticleId IdType="pmc">3552321</ArticleId><ArticleId IdType="doi">10.1126/science.1227157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kum WF, Durairajan SS, Bian ZX, Man SC, Lam YC, Xie LX, Lu JH, Wang Y, Huang XZ, Li M (2011) Treatment of idiopathic Parkinson&#x2019;s disease with traditional Chinese herbal medicine: a randomized placebo-controlled pilot clinical study. Evidence-Based Complementary Alternative Med 1:2011</Citation></Reference><Reference><Citation>Amer DA, Irvine GB, El-Agnaf OM (2006) Inhibitors of &#x3b1;-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson&#x2019;s disease and related disorders. Exp Brain Res 173(2):223&#x2013;233</Citation><ArticleIdList><ArticleId IdType="pubmed">16733698</ArticleId><ArticleId IdType="doi">10.1007/s00221-006-0539-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassallo N (2008) Polyphenols and health: new and recent advances. Nova Publishers, New York</Citation></Reference><Reference><Citation>Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15(6):558</Citation><ArticleIdList><ArticleId IdType="pubmed">18511942</ArticleId><ArticleId IdType="doi">10.1038/nsmb.1437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE (2010) EGCG remodels mature &#x3b1;-synuclein and amyloid-&#x3b2; fibrils and reduces cellular toxicity. Proc Natl Acad Sci 107(17):7710&#x2013;7715</Citation><ArticleIdList><ArticleId IdType="pubmed">20385841</ArticleId><ArticleId IdType="pmc">2867908</ArticleId><ArticleId IdType="doi">10.1073/pnas.0910723107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL (2004) The flavonoid baicalein inhibits fibrillation of &#x3b1;-synuclein and disaggregates existing fibrils. J Biol Chem 279(26):26846&#x2013;26857</Citation><ArticleIdList><ArticleId IdType="pubmed">15096521</ArticleId><ArticleId IdType="doi">10.1074/jbc.M403129200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao JN, Dua V, Ulmer TS (2008) Characterization of &#x3b1;-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry 47(16):4651&#x2013;4656</Citation><ArticleIdList><ArticleId IdType="pubmed">18366183</ArticleId><ArticleId IdType="doi">10.1021/bi8002378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K, Yamada M (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for &#x3b1;-synuclein fibrils in vitro. J Neurochem 97(1):105&#x2013;115</Citation><ArticleIdList><ArticleId IdType="pubmed">16524383</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03707.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T, Hisanaga SI, Goedert M, Hasegawa M (2006) Small molecule inhibitors of &#x3b1;-synuclein filament assembly. Biochemistry 45(19):6085&#x2013;6094</Citation><ArticleIdList><ArticleId IdType="pubmed">16681381</ArticleId><ArticleId IdType="doi">10.1021/bi0600749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong DP, Fink AL, Uversky VN (2008) Structural characteristics of &#x3b1;-synuclein oligomers stabilized by the flavonoid baicalein. J Mol Biol 383(1):214&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pubmed">18775438</ArticleId><ArticleId IdType="pmc">2573395</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2008.08.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Munishkina LA, Fink AL, Uversky VN (2009) Molecular mechanisms underlying the flavonoid-induced inhibition of &#x3b1;-synuclein fibrillation. Biochemistry 48(34):8206&#x2013;8224</Citation><ArticleIdList><ArticleId IdType="pubmed">19634918</ArticleId><ArticleId IdType="doi">10.1021/bi900506b</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R, Shi C, Cao J, Sun Y, Zhao X, Guo Y, Wang C, Lei H, Jiang H, Ablat N, Xu J (2016) Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson&#x2019;s disease. Sci Rep 6(1):1&#x2013;3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-016-0001-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon SM, Jang I, Lee MH, Kim DK, Jeon H, Cha DS (2017) Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans. Pharm Biol 55(1):481&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pubmed">27937005</ArticleId><ArticleId IdType="doi">10.1080/13880209.2016.1251468</ArticleId></ArticleIdList></Reference><Reference><Citation>Briffa M, Ghio S, Neuner J, Gauci AJ, Cacciottolo R, Marchal C, Caruana M, Cullin C, Vassallo N, Cauchi RJ (2017) Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies. Neurosci Lett 18(638):12&#x2013;20</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.11.058</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruana M, H&#xf6;gen T, Levin J, Hillmer A, Giese A, Vassallo N (2011) Inhibition and disaggregation of &#x3b1;-synuclein oligomers by natural polyphenolic compounds. FEBS Lett 585(8):1113&#x2013;1120</Citation><ArticleIdList><ArticleId IdType="pubmed">21443877</ArticleId><ArticleId IdType="doi">10.1016/j.febslet.2011.03.046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain G, Manyam BV (1997) Mucuna pruriens proves more effective than L-DOPA in Parkinson&#x2019;s disease animal model. Phytother Res 11:419&#x2013;423</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1099-1573(199709)11:6&lt;419::AID-PTR120&gt;3.0.CO;2-Q</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav SK, Rai SN, Singh SP (2017) Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. J Chem Neuroanat 1(80):1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.11.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B 827(1):65&#x2013;75</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2005.04.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi KP, Patel NM, Goyal RK (2008) Estimation of L-Dopa from Mucuna pruriens L INN and formulations containing M. pruriens by HPTLC Method. Chem Pharm Bull 56(3):357&#x2013;9</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.56.357</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A, Niranjan SK, Tewari D (2001) Some nutritional properties of the seeds of three Mucuna species. Int J Food Sci Nutr 52(1):79&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">11225181</ArticleId><ArticleId IdType="doi">10.1080/09637480020027264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosal S, Singh S, Bhattacharya SK (1971) Alkaloids of Mucuna pruriens chemistry and pharmacology. Planta Med 19(01):279&#x2013;284</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1099642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Ahmad I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C (2010) Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radical Res 44(8):950&#x2013;965</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2010.492832</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP (2014) Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem Int 1(65):1&#x2013;3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyam BV, Dhanasekaran M, Hare TA (2004) Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytother Res 18(9):706&#x2013;712</Citation><ArticleIdList><ArticleId IdType="pubmed">15478206</ArticleId><ArticleId IdType="doi">10.1002/ptr.1514</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ (2004) Mucuna pruriens in Parkinson&#x2019;s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psych 75(12):1672&#x2013;1677</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.028761</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash J, Yadav SK, Chouhan S, Prakash S, Singh SP (2013) Synergistic effect of Mucuna pruriens and Withania somnifera in a paraquat induced Parkinsonian mouse model. Adv Biosci Biotechnol 4(11):1</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/abb.2013.411A2001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieu CA, Kunselman AR, Manyam BV, Venkiteswaran K, Subramanian T (2010) A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat Disord 16(7):458&#x2013;465</Citation><ArticleIdList><ArticleId IdType="pubmed">20570206</ArticleId><ArticleId IdType="pmc">2909380</ArticleId><ArticleId IdType="doi">10.1016/j.parkreldis.2010.04.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieu CA, Venkiteswaran K, Gilmour TP, Rao AN, Petticoffer AC, Gilbert EV, Deogaonkar M, Manyam BV, Subramanian T (2012) The antiparkinsonian and antidyskinetic mechanisms of Mucuna pruriens in the MPTP-treated nonhuman primate. Evidence-Based Complementary Alternative Med 1:2012</Citation></Reference><Reference><Citation>Uhegbu FO, Elekwa IF, Ukoha C (2005) Comparative efficacy of crude aqueous extract of Mangiferea Indica, Carica Papaya and Sulphadoxine Pyrimethamine on mice infested with malaria parasite in vivo. Global J Pure Appl Sci 11(3):74&#x2013;76</Citation></Reference><Reference><Citation>Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohanakumar KP (2000) Association of L-DOPA with recovery following Ayurveda medication in Parkinson&#x2019;s disease. J Neurol Sci 176(2):124&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pubmed">10930594</ArticleId><ArticleId IdType="doi">10.1016/S0022-510X(00)00329-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohapatra S, Ganguly P, Singh R, Katiyar CK (2020) Estimation of Levodopa in the Unani Drug Mucuna pruriens Bak. and its marketed formulation by high-performance thin-layer chromatographic technique. J AOAC Int. 103(3):678&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">31540588</ArticleId><ArticleId IdType="doi">10.5740/jaoacint.19-0288</ArticleId></ArticleIdList></Reference><Reference><Citation>Saranya G, Jiby MV, Jayakumar KS, Pillai PP, Jayabaskaran C (2020) L-DOPA synthesis in Mucuna pruriens (L.) DC. is regulated by polyphenol oxidase and not CYP 450/tyrosine hydroxylase: an analysis of metabolic pathway using biochemical and molecular markers. Phytochemistry. 178:112467</Citation><ArticleIdList><ArticleId IdType="pubmed">32771675</ArticleId><ArticleId IdType="doi">10.1016/j.phytochem.2020.112467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav SK, Rai SN, Singh SP (2016) Mucuna pruriens shows neuroprotective effect by inhibiting apoptotic pathways of dopaminergic neurons in the paraquat mouse model of parkinsonism. Eur J Pharmaceut Med Res 3:441&#x2013;451</Citation></Reference><Reference><Citation>Rai SN, Dilnashin H, Birla H, Singh SS, Zahra W, Rathore AS, Singh BK, Singh SP (2019) The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotox Res 35(3):775&#x2013;795</Citation><ArticleIdList><ArticleId IdType="pubmed">30707354</ArticleId><ArticleId IdType="doi">10.1007/s12640-019-0003-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 1(71):41&#x2013;49</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2015.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Zahra W, Singh SS, Birla H, Keswani C, Dilnashin H, Rathore AS, Singh R, Singh RK, Singh SP (2019) Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model. Neurotox Res 36(3):452&#x2013;462</Citation><ArticleIdList><ArticleId IdType="pubmed">31016688</ArticleId><ArticleId IdType="doi">10.1007/s12640-019-00038-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra W, Rai SN, Birla H, Singh SS, Rathore AS, Dilnashin H, Singh R, Keswani C, Singh RK, Singh SP (2020) Neuroprotection of rotenone-induced Parkinsonism by ursolic acid in PD mouse model. CNS Neurol Disord-Drug Targets 19(7):527&#x2013;540</Citation><ArticleIdList><ArticleId IdType="pubmed">32787765</ArticleId><ArticleId IdType="doi">10.2174/1871527319666200812224457</ArticleId></ArticleIdList></Reference><Reference><Citation>Adi YK, Widayanti R, Pangestiningsih TW (2018) n-Propanol extract of boiled and fermented koro benguk (Mucuna pruriens seed) shows a neuroprotective effect in paraquat dichloride-induced Parkinson&#x2019;s disease rat model. Vet world 11(9):1250</Citation><ArticleIdList><ArticleId IdType="pubmed">30410229</ArticleId><ArticleId IdType="pmc">6200579</ArticleId><ArticleId IdType="doi">10.14202/vetworld.2018.1250-1254</ArticleId></ArticleIdList></Reference><Reference><Citation>Poddighe S, De Rose F, Marotta R, Ruffilli R, Fanti M, Secci PP, Mostallino MC, Setzu MD, Zuncheddu MA, Collu I, Solla P (2014) Mucuna pruriens (velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1 B9 drosophila melanogaster genetic model of Parkinson&#x2019;s disease. PLoS One. 9(10):e110802</Citation><ArticleIdList><ArticleId IdType="pubmed">25340511</ArticleId><ArticleId IdType="pmc">4207759</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0110802</ArticleId></ArticleIdList></Reference><Reference><Citation>Solari P, Maccioni R, Marotta R, Catelani T, Debellis D, Baroli B, Peddio S, Muroni P, Kasture S, Solla P, Stoffolano JG Jr (2018) The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens. J Insect Physiol 1(111):32&#x2013;40</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinsphys.2018.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SL, Park HY, DaSilva NA, Vattem DA, Ma H, Seeram NP (2018) Levodopa-reduced Mucuna pruriens seed extract shows neuroprotective effects against Parkinson&#x2019;s disease in murine microglia and human neuroblastoma cells, Caenorhabditis elegans, and Drosophila melanogaster. Nutrients 10(9):1139</Citation><ArticleIdList><ArticleId IdType="pmc">6164394</ArticleId><ArticleId IdType="doi">10.3390/nu10091139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G (2018) Daily intake of Mucuna pruriens in advanced Parkinson&#x2019;s disease: a 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord 1(49):60&#x2013;66</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2018.01.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Ma H, DaSilva NA, Rose KN, Johnson SL, Zhang L, Wan C, Dain JA, Seeram NP (2016) Development of a neuroprotective potential algorithm for medicinal plants. Neurochem Int 1(100):164&#x2013;177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2016.09.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer&#x2019;s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25(34):7709&#x2013;7717</Citation><ArticleIdList><ArticleId IdType="pubmed">16120771</ArticleId><ArticleId IdType="pmc">6725245</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.2177-05.2005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner LM, G&#xf6;tz J (2011) Amyloid-&#x3b2; and tau&#x2014;a toxic pas de deux in Alzheimer&#x2019;s disease. Nat Rev Neurosci 12(2):67&#x2013;72</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2967</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association (2015) 2015 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement 11(3):332&#x2013;384</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M (2010) Alzheimer&#x2019;s disease: strategies for disease modification. Nat Rev Drug Discov 9(5):387&#x2013;398</Citation><ArticleIdList><ArticleId IdType="pubmed">20431570</ArticleId><ArticleId IdType="doi">10.1038/nrd2896</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C (2014) Potential for primary prevention of Alzheimer&#x2019;s disease: an analysis of population-based data. Lancet Neurol 13(8):788&#x2013;794</Citation><ArticleIdList><ArticleId IdType="pubmed">25030513</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(14)70136-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88(4):640&#x2013;651</Citation><ArticleIdList><ArticleId IdType="pubmed">24398425</ArticleId><ArticleId IdType="pmc">3992261</ArticleId><ArticleId IdType="doi">10.1016/j.bcp.2013.12.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787&#x2013;795</Citation><ArticleIdList><ArticleId IdType="pubmed">17051205</ArticleId><ArticleId IdType="doi">10.1038/nature05292</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer&#x2019;s disease. Biochim et Biophys Acta 1502(1):139&#x2013;44</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4439(00)00040-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71(2):621S-S629</Citation><ArticleIdList><ArticleId IdType="pubmed">10681270</ArticleId><ArticleId IdType="doi">10.1093/ajcn/71.2.621s</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi DY, Lee YJ, Hong JT, Lee HJ (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer&#x2019;s disease. Brain Res Bull 87(2&#x2013;3):144&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pubmed">22155297</ArticleId><ArticleId IdType="doi">10.1016/j.brainresbull.2011.11.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop JJ, Mucke L (2010) Amyloid-&#x3b2;&#x2013;induced neuronal dysfunction in Alzheimer&#x2019;s disease: from synapses toward neural networks. Nat Neurosci 13(7):812</Citation><ArticleIdList><ArticleId IdType="pubmed">20581818</ArticleId><ArticleId IdType="pmc">3072750</ArticleId><ArticleId IdType="doi">10.1038/nn.2583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS &#x3b2;-amyloid in Alzheimer&#x2019;s disease. Science 330(6012):1774</Citation><ArticleIdList><ArticleId IdType="pubmed">21148344</ArticleId><ArticleId IdType="pmc">3073454</ArticleId><ArticleId IdType="doi">10.1126/science.1197623</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XH, Du LL, Cheng XS, Jiang X, Zhang Y, Lv BL, Liu R, Wang JZ, Zhou XW (2013) Glycation exacerbates the neuronal toxicity of &#x3b2;-amyloid. Cell Death Dis 4(6):e673</Citation><ArticleIdList><ArticleId IdType="pubmed">23764854</ArticleId><ArticleId IdType="pmc">3698547</ArticleId><ArticleId IdType="doi">10.1038/cddis.2013.180</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, M&#xfc;nch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer&#x2019;s disease. Neurobiol Aging 32(5):763&#x2013;777</Citation><ArticleIdList><ArticleId IdType="pubmed">19464758</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.04.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer&#x2019;s disease. Acta Neuropathol 112(4):405&#x2013;415</Citation><ArticleIdList><ArticleId IdType="pubmed">16865397</ArticleId><ArticleId IdType="doi">10.1007/s00401-006-0115-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Subaiea M, Eid A, Li L, Seeram P, Zawia H (2014) Pomegranate extract modulates processing of amyloid-&#x3b2; precursor protein in an aged Alzheimer&#x2019;s disease animal model. Curr Alzheimer Res 11(9):834&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">25274111</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ (2006) The significance of neuroinflammation in understanding Alzheimer&#x2019;s disease. J Neural Transm 113(11):1685</Citation><ArticleIdList><ArticleId IdType="pubmed">17036175</ArticleId><ArticleId IdType="doi">10.1007/s00702-006-0575-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M (2001) Incidence of Alzheimer&#x2019;s disease in a rural community in India: the Indo&#x2013;US study. Neurology 57(6):985&#x2013;989</Citation><ArticleIdList><ArticleId IdType="pubmed">11571321</ArticleId><ArticleId IdType="doi">10.1212/WNL.57.6.985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan T, Ma H, Liu W, Niesen DB, Shah N, Crews R, Rose KN, Vattem DA, Seeram NP (2016) Pomegranate&#x2019;s neuroprotective effects against Alzheimer&#x2019;s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites. ACS Chem Neurosci 7(1):26&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">26559394</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.5b00260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashwlayan VD, Singh RA (2011) Reversal effect of Phyllanthus emblica (Euphorbiaceae) Rasayana on memory deficits in mice. Int J Appl Pharm 3:10&#x2013;15</Citation></Reference><Reference><Citation>Rachsee A, Chiranthanut N, Kunnaja P, Sireeratawong S, Khonsung P, Chansakaow S, Panthong A (2021) Mucuna pruriens (L.) DC. seed extract inhibit lipopolysaccharide-induced inflammatory responses in BV2 microglial cells. J Ethnopharmacol 267:113518</Citation><ArticleIdList><ArticleId IdType="pubmed">33122120</ArticleId><ArticleId IdType="doi">10.1016/j.jep.2020.113518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak VS, Kumar N, D&#x2019;Souza AS, Nayak SS, Cheruku SP, Pai KS (2017) The effects of Mucuna pruriens extract on histopathological and biochemical features in the rat model of ischemia. NeuroReport 28(18):1195&#x2013;1201</Citation><ArticleIdList><ArticleId IdType="pubmed">28953092</ArticleId><ArticleId IdType="doi">10.1097/WNR.0000000000000888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP (2020) Mucuna pruriens in Parkinson&#x2019;s and in some other diseases: recent advancement and future prospective. 3 Biotech. 10(12):1&#x2013;1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-020-02532-7</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rose F, Marotta R, Talani G, Catelani T, Solari P, Poddighe S, Borghero G, Marrosu F, Sanna E, Kasture S, Acquas E (2017) Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS. Sci Rep 7(1):1&#x2013;2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-016-0028-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Velde CV, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52(1):39&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264(5166):1772&#x2013;1775</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId><ArticleId IdType="doi">10.1126/science.8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353(6301):777&#x2013;783</Citation><ArticleIdList><ArticleId IdType="pubmed">27540165</ArticleId><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 21(27):723&#x2013;749</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Fernando SM, Grad LI, Hill AF, Turner BJ, Yerbury JJ, Cashman NR (2016) Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol 36(3):377&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pubmed">26908139</ArticleId><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Poddighe S, Bhat KM, Setzu MD, Solla P, Angioy AM, Marotta R, Ruffilli R, Marrosu F, Liscia A (2013) Impaired sense of smell in a Drosophila Parkinson&#x2019;s model. PLoS One. 8(8):e73156</Citation><ArticleIdList><ArticleId IdType="pubmed">24009736</ArticleId><ArticleId IdType="pmc">3757021</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0073156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Vogel H (2009) Drosophila models of neurodegenerative diseases. Annu Rev Pathol 28(4):315&#x2013;342</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathol.3.121806.151529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasture S, Mohan M, Kasture V (2013) Mucuna pruriens seeds in treatment of Parkinson&#x2019;s disease: pharmacological review. Orient Pharm Exp Med 13(3):165&#x2013;174</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13596-013-0126-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccioni R, Setzu MD, Talani G, Solari P, Kasture A, Sucic S, Porru S, Muroni P, Sanna E, Kasture S, Acquas E (2018) Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS. Sci Rep 8(1):1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34452-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId><ArticleId IdType="doi">10.1126/science.1134108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose JK, Huang CC, Shen CK (2011) Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem 286(52):44441&#x2013;44448</Citation><ArticleIdList><ArticleId IdType="pubmed">22052911</ArticleId><ArticleId IdType="pmc">3247982</ArticleId><ArticleId IdType="doi">10.1074/jbc.M111.237115</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper DC, Adachi Y, Sutcliffe B, Humphrey DM, Elliott CJ, Stepto A, Ludlow ZN, Vanden Broeck L, Callaerts P, Dermaut B, Al-Chalabi A (2013) Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet 22(8):1539&#x2013;1557</Citation><ArticleIdList><ArticleId IdType="pubmed">23307927</ArticleId><ArticleId IdType="pmc">3605831</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddt005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L, Klima R, De Conti L, Romano G, Feiguin F, Buratti E, Baralle M, Baralle FE (2015) An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience 17(311):415&#x2013;421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.10.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F, Godena VK, Romano G, D&#x2019;ambrogio A, Klima R, Baralle FE (2009) Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett 583(10):1586&#x2013;1592</Citation><ArticleIdList><ArticleId IdType="pubmed">19379745</ArticleId><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>